In this issue of the Journal of Adolescent Health, Neilan and coauthors report the findings from their model-based costeffectiveness and clinical impact analysis to determine the optimal age (beginning at age 13 years) for routine one-time HIV screening among US adolescents and young adults without identified HIV risk factors. Read More